House Dust Mite Allergy Treatment Market Set to Witness Unprecedented Growth of USD 5 Billion By 2030, Size, Share, Trends And Growth Opportunities

Data Bridge Market Research conducted a recent market intelligence study, thoroughly analysing the House Dust Mite Allergy Market. The newly published report employs an appealing layout that presents essential data using visually engaging tables, graphs, charts, and figures.

Globalization makes it clear that market research reports hold immense importance for the growth of many businesses. This wide-ranging market analysis document proves to be true in this regard and is designed in a way that is anticipated. It’s the demand or necessity of today’s business to do market research before making any verdict about the products. This is the transparent market report which has been structured with authentic tools and techniques. The market research analysis conducted in the winning business report helps improve the product and also decide about the necessary changes to the future products.

While creating this market report, customer requirements have been understood well and then one method or combination of many methods is used for further processing. In the report, complex market insights are turned into simpler versions with the help of proven tools and techniques and then provided to the clients. A combination of industry insight, practical solutions, talent solutions, and latest technology enhances the customer experience while using this market research report. The market studies, market insights, and market analysis included in this finest report keep the marketplace clearly in focus.

Data Bridge Market Research analyses a growth rate in house dust mite allergy market in the forecast period 2023-2030. The expected CAGR of house dust mite allergy market is tend to be around 13% in the mentioned forecast period. The market was valued at USD 1.88 billion in 2022, and it would grow upto USD 5 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Get a Sample Research Report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-house-dust-mite-allergy-treatment-market

As per WHO records of all types of respiratory allergies, around 70% allergic reactions are related with house dust mites. The incidence of allergic rhinitis accounts for approximately 10-25%, globally. Additionally, as per the World Health Organization (WHO), in 2020, it was reported that about 70% of allergic reactions are caused because of house dust mite allergen.

Key Growth Drivers:

Drivers

• Increasing Drug Approvals

There are different drug approvals by different drug organizations that are helping in boosting the market growth. For instance, in February 2018, Stallergenes Greer and Shionogi & Co., Ltd. received the marketing approval of Actair. It is an allergy immunotherapy drug used to treat house dust mite (HDM) induced allergic rhinitis in Japan. Stallergenes Greer partnered with Shionogi & Co., Ltd. and announced New Drug Application submission for the drug in January 2017. This approval will provide an effective treatment for house dust mite (HDM) induced allergic rhinitis in Japan and will enlarge the business of both the pharmaceutical companies. Furthermore, Merck & Co., Inc. received the U. S. FDA approval in 2017 for Odactra, an anti-allergy drug used to treat house dust mite-induced nasal inflammation in adults. The drug is widely available in oral dosage form and is administered sublingually. This novel drug will deliver a quality treatment to people suffering from house dust mite induced rhinitis and enlarges the business of the company.

The report outlines the involvement of key players, including:

Shionogi & Co., Ltd (Japan), Stallergenes Greer (Switzerland), Merck & Co., Inc (U.S.), Torii Pharmaceutical Co.,Ltd (Japan), Ergomed plc (U.K.), Allergy Therapeutics (U.K.), DMS Imaging (Belgium), HAL Allergy B.V (Netherlands), Trio Lifescience Private Limited (India), Teva Pharmaceutical Industries Ltd (Israel), ICB PHARMA (Poland), Bayer AG (Germany), Sanofi (France), Catalent, Inc (India), GSK Plc. (U.K.), Merz Pharma (Germany)

Know More about This Premium Research Report @ https://www.databridgemarketresearch.com/reports/global-house-dust-mite-allergy-treatment-market

Key Market Segmentation

Diagnosis (Skin Prick Test (SPT), Specific IgE Blood Test, Others), Therapy Type (Medication, Immunotherapy, Nasal Irrigation, Others), Route of Administration (Oral, Nasal, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

The House Dust Mite Allergy market report includes the following countries in different regions:

The regions mentioned above encompass a comprehensive coverage of key markets, offering a global perspective on the market landscape. Here’s an overview of the regions and the countries they include:

1. North America: United States, Canada, and Mexico.
2. Europe: Germany, France, United Kingdom, Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, and other European countries.
3. Asia-Pacific (APAC): China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and other Asia-Pacific countries.
4. Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates (U.A.E), South Africa, Egypt, Israel, and other countries in the Middle East and Africa region.
5. South America: Brazil, Argentina, and other countries in South America.

TABLE OF CONTENTS

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Market Landscape

Part 05: Pipeline Analysis

Part 06: Market Sizing

Part 07: Five Forces Analysis

Part 08: Market Segmentation

Part 09: Customer Landscape

Part 10: Regional Landscape

Part 11: Decision Framework

Part 12: Drivers And Challenges

Part 13: Market Trends

Part 14: Vendor Landscape

Part 15: Vendor Analysis

Part 16: Appendix

Get the Complete Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-house-dust-mite-allergy-treatment-market

Browse More Reports:

https://www.databridgemarketresearch.com/reports/global-eosinophil-driven-diseases-market

https://www.databridgemarketresearch.com/reports/global-barretts-esophagus-market

https://www.databridgemarketresearch.com/reports/global-renal-drugs-market

https://www.databridgemarketresearch.com/reports/global-edema-treatment-market

https://www.databridgemarketresearch.com/reports/global-preventable-vaccines-market

https://www.databridgemarketresearch.com/reports/global-pancreatic-cancer-treatment-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability level and advanced approaches. We are committed to uncover the best consumer prospects and to foster useful knowledge for your company to succeed in the market.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe.

Contact Us

US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email – corporatesales@databridgemarketresearch.com